Owl Creek Wealth Partners’s RxSight RXST Stock Holding History

Owl Creek Wealth Partners’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30	Closed	-$185	–	1334
2026 Q1	$185	Buy	+30	New	+$249	﹤0.01%	1228

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 37.48% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Owl Creek Wealth Partners's RXST Position: Q2 2026 in Review

Owl Creek Wealth Partners sold out of RxSight (RXST) in Q2 2026, closing a stake of 30 shares — an estimated $185 sold.

Owl Creek Wealth Partners first reported a position in RXST in Q1 2026 and held it in 1 quarter. The position peaked at $185 in Q1 2026. 137 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Owl Creek Wealth Partners reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
Owl Creek Wealth Partners sold 30 RxSight shares in Q2 2026, an estimated $185.
Owl Creek Wealth Partners first reported a position in RxSight in Q1 2026 and held it in 1 quarter.
Owl Creek Wealth Partners's RxSight position peaked at $185 in Q1 2026.
137 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.